Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool January 21, 2010 Brian Orelli	The Noble Gesture That Wasn't There may be a motive behind Glaxo helping to develop malaria treatments.
Chemistry World December 19, 2007 Hepeng Jia	Boom and Bust for Antimalarial Industry At first there was a global shortage, but now a surplus of artemisinin threatens to put some drug manufacturers out of business.
Chemistry World April 2008 Victoria Gill	Malaria no More? A fresh round of research funding could put an end to the killer disease.
Chemistry World August 18, 2006 Bea Perks	Resistance is Futile Resistance to malaria drugs poses a serious problem in countries where the disease is endemic. But researchers have now reported the synthesis of a hybrid molecule that combines chloroquine with a molecule that reverses resistance.
HHMI Bulletin Aug 2010 Robert Koenig	Collaborating Across an Ocean to Stop Malaria Two scholars, one from Mali and one from the United States team up to produce a vaccine for malaria.
Chemistry World May 3, 2012 Akshat Rathi	Ranbaxy launches new anti-malarial Synriam It is the first recently developed antimalarial that is not based on artemisinin, one of the most effective treatments for malaria, which has begun to suffer from problems with resistance in recent years.
Chemistry World April 9, 2009 Phillip Broadwith	Dual-action malaria drug reverses resistance US chemists have designed a new class of antimalarial drug that can reverse the malaria parasite's resistance to existing drugs.
Scientific American October 2007 Jeffrey D. Sachs	Ending Malaria Deaths in Africa One of the world s worst killers can be stopped soon if we make the investment.
BusinessWeek January 17, 2005 Einhorn & Kripalani	Wanted: New Weapons Against An Old Killer Many of the new malaria medicines are in early stages of development. But with tsunami-hit countries receiving billions in aid there may finally be both the will and the means to tackle one of the world's most dangerous diseases.
Chemistry World June 17, 2015 James Urquhart	Promising compound offers single dose knock-out for malaria Ian Gilbert and colleagues, working with the Medicines for Malaria Venture, have found a compound dubbed DDD107498 which kills Plasmodium falciparum -- the species responsible for most dangerous form of malaria.
Scientific American September 2007 Jeffrey D. Sachs	Ending Malaria Deaths in Africa One of the world's worst killers can be stopped soon if we make the investment.
Chemistry World March 21, 2013 Phillip Broadwith	New antimalarial drug class resists resistance Early indications also show that it may take longer for the parasite to develop resistance to the new molecules than it has for existing drugs targeting the same pathway.
Chemistry World April 25, 2013 Phillip Broadwith	Portable detector shines light on fake drugs The CD-3 counterfeit detection device uses a variety of different wavelengths of light to visually compare tablets, capsules and their packaging with genuine reference samples.
Chemistry World April 25, 2007 Richard Van Noorden	Malaria Drug Cures Mice with Single Dose U.S. chemists have adapted a Chinese herbal medicine to create a new generation of antimalarial drugs which could solve some of the current crop's failings.
BusinessWeek May 13, 2010 Simeon Bennett	Mobile Phones Fight Africa's Drug Wars New systems that let users dial up to verify antimalarial and other drugs' authenticity could be a major defense against counterfeit meds.
The Motley Fool March 30, 2011 Sean Williams	China Clamps Down on Drug Manufacturers These drug manufacturers could be feeling a pinch from new Chinese price caps.
Pharmaceutical Executive July 1, 2013 Jill Wechsler	Seeking Supply Chain Security FDA wants pharma leaders to do more to ensure drug quality at home and abroad.
HHMI Bulletin February 2011 Sarah C.P. Williams	Warming Malaria Climate change is expanding the disease-causing pathogen's comfort zone.
The Motley Fool March 29, 2006 Stephen D. Simpson	Novartis Bulks Up Its Pipeline The Swiss drug giant once again pays up to add trial candidates to its portfolio. Investors, take note.
Chemistry World October 2010 Bibiana Campos Seijo	Editorial: Healing the world Although the role of science has not been strongly emphasised in discourse surrounding the Millennium Development Goals, the work of scientists contributes towards making the world a better place.
Chemistry World July 3, 2006 Mark Peplow	Drug Screen Reveals Antimalarial Agent A widely-available antihistamine called astemizole could help in the battle against malaria, according to a survey of more than 2,600 drugs in a pharmaceutical library.
Chemistry World December 15, 2011	Eastern promise Yongyuth Yuthavong discusses the challenges that face scientists in Thailand with Kathleen Too.
Salon.com December 15, 2000 Arthur Allen	Warming to malaria With fears mounting that global climate change may cause the dreaded disease to spread, scientists turn their attention to vaccine research...
The Motley Fool April 6, 2010 Brian Orelli	Kill It! Double-Teaming Malaria Malaria vaccine might not make Glaxo and Crucell rich, but the life-saving and PR benefits would be welcome.
The Motley Fool July 17, 2006 Stephen D. Simpson	Novartis Pays for Its Shopping Spree Expenses from the Chiron acquisition bring down results for the second quarter. Investors, there's a lot to be said for waiting on the right price for even the best stocks out there.
Bio-IT World Dec 2005/Jan 2006 Salvatore Salamone	Gates, Clinton Address Global Health Summit The conference brought together leaders in business, government, medicine, public philanthropic groups, and the arts to address and develop solutions to the world's heath crises.
Chemistry World January 18, 2013 Emma Eley	New method to target malaria Malaria affects millions of people each year; however, no effective vaccines exist. Now, scientists from Spain have discovered a new strategy to target the disease.
Chemistry World May 2007 Lisa Melton	Chinese Medicine in Western Packaging The past decade has seen a global awakening to the truly curative powers of many ancient medicines, from black bear bile to the Asian plant Epimedium.
The Motley Fool July 21, 2004 Brian Gorman	Novartis Shows the Way It may be a model for other pharmaceutical outfits looking to improve productivity.
Chemistry World August 7, 2012 Emma Eley	Improved drugs to treat malarial liver infection Antimalarial drugs with increased in vitro activity have been developed by scientists in Portugal and the US. These novel drugs, called primacins, are active against two stages of malarial infection.
Geotimes May 2005 Jeffrey Shaman	Malaria Mapping and Prevention Today, scientists from various fields, including the geosciences, are contributing to the fight against malaria and other infectious diseases.
Chemistry World May 31, 2013 Phillip Broadwith	Japanese pharma opens compound vaults Japanese pharmaceutical companies are opening up their libraries of experimental compound as part of a new partnership program. The initiative aims to find new drugs for malaria, tuberculosis and neglected tropical diseases.
The Motley Fool October 22, 2007 Brian Lawler	No Catastrophes at Novartis Novartis stays on track with its third-quarter results. Investors, take note.
The Motley Fool October 23, 2006 Brian Lawler	No Slowing Novartis The Swiss pharmaceutical company shows strength in nearly all its divisions. Novartis looks like a good investment for risk-adverse investors searching for a large-cap pharma stock.
American Family Physician August 1, 2003	Preventing Malaria When You Travel What is malaria? Who gets it?... How is malaria transmitted?... Who is at risk for malaria?... How can I tell if I have malaria?... Can I do anything to keep from getting malaria?... What should I do if I think I have malaria?... etc.
Chemistry World February 15, 2008 James Mitchell Crow	Industry Reports a Year of Mixed Fortune Despite the twin pressures of rising energy and feedstock prices, and a slowing economy in the US curbing demand, many companies in the chemical sectors have reported rising sales and profits in their financial reviews of 2007.
Chemistry World February 24, 2011 Laura Howes	Seaweed recruited in fight against malaria Compounds found in seaweed have shown anti-malarial properties, killing even drug-resistant malaria parasites.
The Motley Fool October 21, 2008 Brian Orelli	Novartis Is Taking the Road Less Traveled Diversification should pay off for this pharma giant.
Chemistry World April 17, 2013 Mark Peplow	Sanofi launches malaria drug production On 11 April, the Paris-based pharmaceutical company Sanofi officially launched a new production facility in Garessio, Italy, to make artemisinin -- the precursor to artemisinin-based combination therapies, the most effective drugs against the deadliest malaria parasite.
The Motley Fool March 16, 2005 Cliff Malings	Nice of You to Notice Novartis The Street finally pays attention to a longtime pharma winner on news of a major generic-drug acquisition.
Fast Company September 2006 Tonya Garcia	Miracle Microbes In the labs of Amyris Biotechnologies, molecular manipulation may yield cheap and effective malaria drugs.
Chemistry World May 3, 2011 Michael Gross	New hope for malaria drugs as sickle cell protection unravelled Researchers have come up with a molecular mechanism that explains how it protects people from this deadly disease.
The Motley Fool July 16, 2010 Brian Orelli	A Positive Sign for Pharma Earnings Season Strong first-half results drove Novartis to increase its sales guidance for the year.
Chemistry World October 9, 2013 Phillip Broadwith	GSK to apply for malaria vaccine approval Preliminary results from the first ever Phase III clinical trial of a malaria vaccine show that it can reduce malaria infections in vaccinated children over 18 months.
The Motley Fool January 19, 2006 Stephen D. Simpson	Novartis Marches On While reported profits are masked by some charges, this Swiss drug company is still delivering the goods. Throw in a solid pipeline and a reasonable valuation, and the stock could still be worth a look for new money in the pharmaceutical space.
Chemistry World July 2010	Supporting science The Wellcome Trust is one of the largest science funding bodies in the world. Sir Mark Walport, the trust's director, tells Phillip Broadwith how it spends its money
The Motley Fool January 20, 2005 Stephen D. Simpson	Novartis Posts a Swiss Miss The Swiss drug giant has a strong pipeline, but moderate growth and high valuation suggest little room for error.
Chemistry World October 18, 2012 Jessica Cocker	Killing three parasites with one stone Scientists in the US have developed a hybrid drug that is active against malaria, schistosomiasis or hookworm.
Chemistry World November 1, 2011 Sarah Houlton	A Shot in the Arm for Drugs for Neglected Diseases A new consortium of public and private sector partners has been launched by the World Intellectual Property Organization. Its aim is to share intellectual property that may help find drugs for malaria, tuberculosis and other neglected tropical diseases.
Science News February 3, 2007	Science Safari: Malaria Control In a project coordinated by CERN, volunteer computers in homes and offices run a simulation program called MalariaControl.net, developed by researchers at the Swiss Tropical Institute.